Last reviewed · How we verify
NCT05804331: ANZ UGI
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
trial in Cancer of Stomach in 500 participants. Currently enrolling.
14 March 2028
Quick facts
| Lead sponsor | Western Sydney Local Health District |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 14 March 2023 |
| Primary completion | 14 March 2028 |
| Estimated completion | 14 September 2028 |
| Sites | 1 location across Australia |
Conditions studied
- Cancer of Stomach — all drugs for Cancer of Stomach →
- Oesophageal Cancer — all drugs for Oesophageal Cancer →
- Gastric Cancer — all drugs for Gastric Cancer →
- Gastric Adenocarcinoma — all drugs for Gastric Adenocarcinoma →
Sponsor
Western Sydney Local Health District — full company profile →
Who can join
18 and older, any sex, with Cancer of Stomach or Oesophageal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05804331
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer of Stomach
Currently open trials in the same condition.
- NCT07072728 — Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder · Phase 2 · recruiting
- NCT06940778 — LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TU · active not recruiting
- NCT05179824 — Tempus Priority Study: A Pan-tumor Observational Study · active not recruiting
- NCT03347162 — Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer · active not recruiting
Other Western Sydney Local Health District trials
Trials by the same sponsor.
- NCT07445334 — Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes · NA · not yet recruiting
- NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
- NCT06365411 — GEnomic Medicine in Kidney Transplantation Study · not yet recruiting
- NCT06828562 — GENomic Predictors in A Multi-Ethnic Population With Kidney Disease Study · enrolling by invitation
- NCT05509153 — A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05804331 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Western Sydney Local Health District
- Last refreshed: 27 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05804331.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing